• Integra Foods' new dry fractionation facility separates starches from proteins in faba beans to produce 15,000 metric tonnes of all-natural concentrates annually.
    Integra Foods' new dry fractionation facility separates starches from proteins in faba beans to produce 15,000 metric tonnes of all-natural concentrates annually.
Close×

Integra Foods, a subsidiary of Australian Grain Export (AGE), has launched its plant protein facility, located in AGE’s new $20 million vertically integrated precinct in Dublin, South Australia. Using a dry fractionation process, the facility will produce 15,000 metric tonnes of all-natural concentrates annually.

Integra Foods' state-of-the-art facility is fitted with equipment sourced from Buhler and Hosokawa Alpine, and is pioneering a dry fractionation technique to produce 15,000 metric tonnes of all-natural concentrates from pulses annually. The environmentally friendly process separates starches from proteins in faba beans, ensuring minimal impact on their natural structure.

Integra Foods MD Tim Martin said Integra was aiming to solidify its position as a global leader in sustainable plant protein production.

“Our dry fractionation process produces high-quality protein and starch concentrates and reduces energy consumption significantly,” said Martin.

Under the dry fractionation method, Integra Foods separates proteins and starches without using water, acids, alkalis, solvents, or drying, ensuring a sustainable and energy-efficient production process.

This technique is 90 per cent more energy efficient than traditional wet fractionating methods, preserving the natural integrity of the grains.

Integra Foods' commitment to sustainability extends beyond production processes. By sourcing faba beans grown within 150 kilometres of the manufacturing site, the company reduces food miles and supports local growers, contributing to a healthier and more prosperous planet.

Integra plans to export its plant protein ingredients to key markets in Asia, Europe, and North America.

Packaging News

Australian packaging innovator TomKat Global Solutions has opened expressions of interest for its upcoming wholesale equity raise, as it seeks to accelerate the global commercial rollout of its KoolPak reusable packaging system.

Dr Jane Oppenheim, chief executive officer & director of Ego Pharmaceuticals, has been inducted into the Victorian Manufacturing Hall of Fame’s Honour Roll for Service to Industry.

Australian packaging innovator TomKat Global Solutions has signed an exclusive supply agreement with Thai Sekisui Foam and Sekisui Foam Australia, marking a major step in its expansion into Southeast Asia.